New AACE Guidelines for Non-Alcoholic Fatty Liver Disease - Frankly Speaking Ep 302 - a podcast by Pri-Med

Credits: 0.25 AMA PRA Category 1 Credit™
 

 

CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-302

 

Overview: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the United States, with a prevalence rate of more than 30% of US adults. Most have not been diagnosed or treated. Join us to discuss the new AACE guidance on the diagnosis and treatment of NAFLD to reduce the burden of this common disease.

 

Episode resource links:

• AACE Guideline:  Endocrine Pract: May 2022, 28(5): 528-562


• Coffee: Front Pharmacol. 2021 Dec 13;12:786596. doi: 10.3389/fphar.2021.786596

 

Guest: Robert A. Baldor, MD

 

Music Credit: Richard Onorato
 

Further episodes of Frankly Speaking About Family Medicine

Further podcasts by Pri-Med

Website of Pri-Med